ATE451475T1 - Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben - Google Patents

Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben

Info

Publication number
ATE451475T1
ATE451475T1 AT04777581T AT04777581T ATE451475T1 AT E451475 T1 ATE451475 T1 AT E451475T1 AT 04777581 T AT04777581 T AT 04777581T AT 04777581 T AT04777581 T AT 04777581T AT E451475 T1 ATE451475 T1 AT E451475T1
Authority
AT
Austria
Prior art keywords
cns
systems
nervous system
central nervous
samples
Prior art date
Application number
AT04777581T
Other languages
English (en)
Inventor
Osvaldo Podhajcer
Fernando Pitossi
Marcelo Rubinstein
Original Assignee
Gentron Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentron Llc filed Critical Gentron Llc
Application granted granted Critical
Publication of ATE451475T1 publication Critical patent/ATE451475T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT04777581T 2003-07-03 2004-07-02 Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben ATE451475T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48468303P 2003-07-03 2003-07-03
US48472603P 2003-07-03 2003-07-03
PCT/US2004/021543 WO2005007892A1 (en) 2003-07-03 2004-07-02 Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples

Publications (1)

Publication Number Publication Date
ATE451475T1 true ATE451475T1 (de) 2009-12-15

Family

ID=34083317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04777581T ATE451475T1 (de) 2003-07-03 2004-07-02 Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben

Country Status (8)

Country Link
US (2) US20060263783A1 (de)
EP (1) EP1649062B1 (de)
JP (1) JP2007531494A (de)
AT (1) ATE451475T1 (de)
AU (1) AU2004258101B2 (de)
CA (1) CA2531281A1 (de)
DE (1) DE602004024539D1 (de)
WO (1) WO2005007892A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2094871A4 (de) * 2006-11-16 2010-03-31 Gentron Llc Verfahren, systeme und zusammensetzungen zur diagnose von krebs
WO2009012340A2 (en) * 2007-07-16 2009-01-22 California Institute Of Technology Microfluidic devices, methods and systems for detecting target molecules
JPWO2009020058A1 (ja) * 2007-08-03 2010-11-04 学校法人慶應義塾 脱髄病変へのドラッグデリバリーシステム及び脱髄病変の生化学的マーカー
JP5458359B2 (ja) * 2007-10-18 2014-04-02 独立行政法人理化学研究所 ヒト白血病幹細胞および白血病非幹細胞が増幅されたマウスおよびその製造方法
WO2010030293A1 (en) * 2008-09-15 2010-03-18 Gentron, Inc. Methods, systems, and compositions for cancer diagnosis
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
JP2011149859A (ja) * 2010-01-22 2011-08-04 Igaku Seibutsugaku Kenkyusho:Kk 食道癌マーカー
US20130151197A1 (en) * 2011-11-23 2013-06-13 General Electric Company Automated performance measurement processes and systems
US8912159B2 (en) * 2012-02-24 2014-12-16 National Institutes Of Health (Nih) Analyzing semaphorin7a (Sema7A) levels for assessing cancer metastatic potential and methods of treatment
EP2888349B1 (de) 2012-08-24 2022-02-09 Yale University System, vorrichtung und verfahren für multiplex-erkennung mit hohem durchsatz
DK3227684T3 (da) 2014-12-03 2019-11-11 Isoplexis Corp Analyse af og screening for cellesekretionsprofiler
US11353448B2 (en) 2015-02-13 2022-06-07 California Institute Of Technology Methods and compositions for quantifying metabolites and proteins from single cells
UA124612C2 (uk) * 2015-02-24 2021-10-20 Рупрехт-Карлс-Універсітет Гейдельберг Панель біомаркерів для виявлення раку
EP3510398B1 (de) 2016-09-12 2026-02-25 Isoplexis Corporation System und verfahren zur multiplex-analyse von zellularen und anderen immunotherapeutika
EP3538891B1 (de) 2016-11-11 2022-01-05 Isoplexis Corporation Zusammensetzungen und verfahren zur gleichzeitigen genomischen, transkriptomischen und proteomischen analyse von einzelzellen
CN110226084A (zh) 2016-11-22 2019-09-10 伊索普莱克西斯公司 用于细胞捕获的系统、装置和方法，以及其制造方法
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
KR102100588B1 (ko) * 2019-06-24 2020-04-13 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR20210000253A (ko) * 2019-12-16 2021-01-04 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207696B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207699B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207697B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR20210000255A (ko) * 2019-12-16 2021-01-04 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물
KR102207698B1 (ko) * 2019-06-24 2021-01-26 재단법인 대구경북첨단의료산업진흥재단 뇌미세혈관 손상 뇌질환 진단용 바이오 마커 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005864A1 (en) * 1993-08-27 1995-03-02 Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Convection-enhanced drug delivery
CA2350165C (en) * 1998-11-20 2011-12-13 Fuso Pharmaceutical Industries, Ltd. Novel serine protease bssp6
JP2003505749A (ja) * 1999-02-23 2003-02-12 ワーナー−ランバート カンパニー 遺伝子発現プロファイリングに由来する情報の管理と提示のためのシステムと方法
EP1179175A2 (de) * 1999-05-14 2002-02-13 Karolinska Innovations AB Materialien und verfahren in verbindung mit krankheitsdiagnose
ATE452989T1 (de) * 2000-03-27 2010-01-15 Univ Jefferson Zusammensetzungen und methoden zur identifizierung von krebszellen
US6372250B1 (en) * 2000-04-25 2002-04-16 The Regents Of The University Of California Non-invasive gene targeting to the brain
WO2002024956A2 (en) * 2000-09-19 2002-03-28 Whitehead Institute For Biomedical Research Genetic markers for tumors
CN1526025A (zh) * 2001-05-16 2004-09-01 ��˹��ŵ�� 作为预后和治疗靶标的乳腺癌中表达的基因
JP5236856B2 (ja) * 2001-11-09 2013-07-17 ライフ テクノロジーズ コーポレーション 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定

Also Published As

Publication number Publication date
US20060263783A1 (en) 2006-11-23
EP1649062A1 (de) 2006-04-26
WO2005007892A1 (en) 2005-01-27
AU2004258101A1 (en) 2005-01-27
US20110251077A1 (en) 2011-10-13
EP1649062B1 (de) 2009-12-09
AU2004258101B2 (en) 2010-12-23
CA2531281A1 (en) 2005-01-27
JP2007531494A (ja) 2007-11-08
DE602004024539D1 (de) 2010-01-21

Similar Documents

Publication Publication Date Title
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
WO2008070137A3 (en) Interferon alpha-induced pharmacodynamic markers
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
EP4257705A3 (de) Biomarker für traumatische hirnverletzungen
IL172488A0 (en) Diagnostic methods for monitoring immunologic, hematologic and inflammatory diseases
WO2007033216A3 (en) Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EA200600920A1 (ru) Иммуносорбентные исследования крови для оценки пароксизмальных церебральных разрядов
WO2007080597A3 (en) Polynucleotide and polypeptide sequences and methods for diagnosis
ATE511651T1 (de) Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
EP2365335A3 (de) Diagnoseverfahren
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
WO2004045376A3 (en) Screening methods to identify treatments for autoimmune disease
MX2021009829A (es) Biomarcadores salivales de lesion cerebral.
EP2189541A3 (de) Methoden und Reagentien für die Behandlung und die Diagnose von altersbedingter makularer Degeneration
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
WO2008008487A3 (en) Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
ATE465408T1 (de) Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins
DE602004027534D1 (de) Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties